News
The Impressive Rise of the U.S. Dollar Continues
The U.S. dollar is on an impressive rise, achieving historic milestones and surprising traders. It is currently set for a 12th consecutive week of gains, with p...
European Commission Investigates Chinese Subsidies for Battery-Electric Car Makers
The European Commission is investigating Chinese subsidies for battery-electric car makers in Europe and their potential impact on the industry. The investigati...
GM Secures $6 Billion Credit Agreement Amidst UAW Strike
General Motors secures a $6 billion credit agreement amidst the ongoing UAW strike, impacting operations and resulting in layoffs.
Greggs Sales Surge by Over 20%
Greggs reports a surge in sales of over 20%, driven by affordable pricing and cost-conscious consumers. The company plans to expand and open new stores.
Benchmark Bond Yields Maintain 16-Year Highs
Benchmark bond yields are at a 16-year high, influenced by factors such as the stability of the 10-year Treasury yield and recent positive manufacturing surveys...
Oxford BioDynamics Receives Reimbursement Code for Prostate Cancer Screening Test
Oxford BioDynamics receives reimbursement code for their prostate cancer screening test, EpiSwitch, simplifying billing and ensuring accurate reimbursement. The...
Aurrigo International Partners with International Consolidated Airlines Group
Transport technology company Aurrigo International partners with International Consolidated Airlines Group to deploy self-driving baggage and air-freight vehicl...
Sanofi and Johnson & Johnson Partner to Develop Vaccine Against Extraintestinal Pathogenic Escherichia coli
Sanofi and Johnson & Johnson team up to develop a vaccine against extraintestinal pathogenic Escherichia coli (E. coli) and address antimicrobial resistance. Th...
Jabil Announces restructuring plan and cost estimates
Jabil Inc. announces restructuring plan involving headcount reductions and $200 million estimated cost following partnership with BYD Electronics.
Syros Pharmaceuticals Faces Challenges
Syros Pharmaceuticals faces challenges as CEO resigns, staff is reduced, and stock price plummets. Company adjusts priorities and focuses on key drug candidate.